Ke‐Ping Shen
Impact in
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
Papers in
-
- Retinoids in leukemia and cellular processes 2
- Natural product bioactivities and synthesis 2
- Oncology 6
- Cancer-related Molecular Pathways 2
- Co-authors
- Hong‐Mei An (10 shared papers)Shan Deng (6 shared papers)Mengmeng Wei (4 shared papers)Bing Hu (3 shared papers)Bing Hu (8 shared papers)Ling Xu (4 shared papers)Ling Xu (1 shared paper)Qin Du (3 shared papers)
- Journals
- Oncology Reports (3 papers)Cancer Biotherapy and Radiopharmaceuticals (1 paper)BMC Complementary Medicine and Therapies (1 paper)Food Additives & Contaminants Part A (1 paper)World Journal of Microbiology and Biotechnology (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Ke‐Ping Shen
21 papers receiving 422 citations
Peers
Comparison fields: 5 of 67
- Molecular Medicine 61
- Geriatrics and Gerontology 17
- Complementary and alternative medicine 31
- Biochemistry 19
- Pharmacology 25
Countries citing papers authored by Ke‐Ping Shen
This map shows the geographic impact of Ke‐Ping Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke‐Ping Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke‐Ping Shen more than expected).
Fields of papers citing papers by Ke‐Ping Shen
This network shows the impact of papers produced by Ke‐Ping Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke‐Ping Shen. The network helps show where Ke‐Ping Shen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke‐Ping Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 100 | |
| 2 | 2014 | 48 | |
| 3 | 2013 | 38 | |
| 4 | 2014 | 34 | |
| 5 | 2016 | 28 | |
| 6 | 2019 | 26 | |
| 7 | 2011 | 25 | |
| 8 | 2021 | 23 | |
| 9 | 2020 | 23 | |
| 10 | 2020 | 15 | |
| 11 | 2020 | 14 | |
| 12 | 2021 | 13 | |
| 13 | 2012 | 11 | |
| 14 | 2011 | 10 | |
| 15 | [Clinical study on post-operative metastasis prevention of progressive stage of gastric cancer by weichang'an]. | 2003 | 7 |
| 16 | [Effect of Solanum nigrum on human colon carcinoma RKO cells ]. | 2013 | 6 |
| 17 | Compatibility of Chinese Anti-cancer Herb | 2010 | 3 |
| 18 | Shiquan Yuzhen Decoction inhibits angiogenesis and tumor apoptosis caused by non-small cell lung cancer and promotes immune response. | 2021 | 3 |
| 19 | Clinical Research of Curative Effect of Malignant Partial Intestinal Obstruction Treated with Anus Catheter Infusion of Herbs plus Chemotherapy | 2008 | 1 |
| 20 | Low dose of etoposide induces cell senescence in colon carcinoma. | 2009 | 1 |
About Ke‐Ping Shen
Ke‐Ping Shen is a scholar working on Molecular Biology, Oncology, Cancer Research, Complementary and alternative medicine and Immunology, having authored 21 papers that have together received 430 indexed citations. Recurring topics across this work include Traditional Chinese Medicine Analysis (3 papers), Retinoids in leukemia and cellular processes (2 papers), Cancer-related Molecular Pathways (2 papers), Immune cells in cancer (2 papers), Cancer Mechanisms and Therapy (2 papers), NF-κB Signaling Pathways (2 papers), Plant Pathogens and Fungal Diseases (2 papers) and Natural product bioactivities and synthesis (2 papers). The work is most often cited by research in Molecular Medicine (61 citations), Geriatrics and Gerontology (17 citations), Complementary and alternative medicine (31 citations), Biochemistry (19 citations) and Pharmacology (25 citations). Ke‐Ping Shen has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Hong‐Mei An, Shan Deng, Mengmeng Wei, Bing Hu, Bing Hu, Ling Xu, Ling Xu, Qin Du, Yang Wu and Shuangshuang Wang. Their work appears in journals such as Oncology Reports, Cancer Biotherapy and Radiopharmaceuticals, BMC Complementary Medicine and Therapies, Food Additives & Contaminants Part A and World Journal of Microbiology and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.